| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/29/2022 | 271.62% | HC Wainwright & Co. | $7 → $5.5 | Maintains | Buy |
| 08/16/2022 | — | Oppenheimer | Downgrades | Outperform → Perform | |
| 08/11/2022 | 62.16% | B. Riley Securities | $6 → $2.4 | Downgrades | Buy → Neutral |
| 06/07/2022 | 372.97% | HC Wainwright & Co. | $8 → $7 | Maintains | Buy |
| 05/13/2022 | 305.41% | B. Riley Securities | $8 → $6 | Maintains | Buy |
| 04/18/2022 | 440.54% | HC Wainwright & Co. | $12 → $8 | Maintains | Buy |
| 03/10/2022 | 440.54% | B. Riley Securities | $16 → $8 | Maintains | Buy |
| 03/08/2022 | 372.97% | Roth Capital | → $7 | Initiates Coverage On | → Buy |
| 08/04/2021 | 710.81% | HC Wainwright & Co. | $11 → $12 | Maintains | Buy |
| 05/10/2021 | 643.24% | HC Wainwright & Co. | $16 → $11 | Maintains | Buy |
| 03/16/2021 | 981.08% | HC Wainwright & Co. | $7 → $16 | Maintains | Buy |
| 08/18/2020 | 372.97% | HC Wainwright & Co. | $6 → $7 | Maintains | Buy |
| 10/16/2019 | 305.41% | Oppenheimer | → $6 | Initiates Coverage On | → Outperform |
| 02/14/2019 | 372.97% | B. Riley Securities | → $7 | Initiates Coverage On | → Buy |
| 09/25/2017 | 372.97% | Ladenburg Thalmann | → $7 | Initiates Coverage On | → Buy |
ChromaDex Questions & Answers
The latest price target for ChromaDex (NASDAQ: CDXC) was reported by HC Wainwright & Co. on August 29, 2022. The analyst firm set a price target for $5.50 expecting CDXC to rise to within 12 months (a possible 271.62% upside). 8 analyst firms have reported ratings in the last year.
The latest analyst rating for ChromaDex (NASDAQ: CDXC) was provided by HC Wainwright & Co., and ChromaDex maintained their buy rating.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of ChromaDex, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for ChromaDex was filed on August 29, 2022 so you should expect the next rating to be made available sometime around August 29, 2023.
While ratings are subjective and will change, the latest ChromaDex (CDXC) rating was a maintained with a price target of $7.00 to $5.50. The current price ChromaDex (CDXC) is trading at is $1.48, which is out of the analyst's predicted range.